Medical Research News
Focus on the latest clinical studies, reports, findings, programs and standards covering a wide spectrum of medical and health issues. This section highlights research into human populations and includes information about research facilities, funding, resources and public policy.
IonSense Expands Product Line with ASAP Open-Air Ionization Source
IonSense to sell Atmospheric Solids Analysis Probe (ASAP) as Entry Level Source for Open-Air Mass Spectrometry - October 08, 2010 - IonSense, Inc.
Adaptive Site Monitoring Improves Clinical Research Efficiency: DIA Invites Health Decisions to Discuss
Health Decisions CEO Dr. Michael Rosenberg will explore the implications of advanced e-monitoring models during two sessions at the DIA 4th Annual Clinical Forum. - October 08, 2010 - Health Decisions
Microfluidic Devices Advance 3D Tissue Engineering at Stevens
A research team, co-headed by Dr. Woo Lee and Dr. Hongjun Wang of Stevens Institute of Technology, has published a paper describing a new method that generates three-dimensional (3D) tissue models for studying bacterial infection of orthopedic implants. The paper, appearing in the journal Tissue Engineering, demonstrates a physiologically relevant approach for studying infection prevention strategies and emulating antibiotic delivery using 3D bone tissues cultured in microfluidic devices. - October 07, 2010 - Stevens Institute of Technology
RayBiotech and Gentel Partner to Offer Comprehensive Selection of Arrays on APiX Chromogenic Detection Platform
RayBiotech, Inc., a pioneer and leader in protein and antibody array technologies, and Gentel Biosciences, a leader in proteomics profiling tools, jointly announced today their partnership to develop and market RayBiotech's vast collection of easy-to-use antibody array products for use with Gentel's APiX™ chromogenic detection platform, a cost-effective alternative to laser fluoresecence scanners. - October 05, 2010 - RayBiotech, Inc
New White Paper Report from Medimix International
50,000 Interviews done between 2006-2010 reveal cultural differences that affect concept testings. Study compared the way healthcare professionals from 20 countries use scoring scales for the five key metrics of Medimix's PromotestTM; specifically: Clarity, Relevance to Practice, Originality, Credibility, and Intention to Prescribe. - September 30, 2010 - Medimix International
FRP Advisory Pledges Its Support to National Jeans for Genes Day on Friday 1 October 2010
Jeans for Genes Day is an annual fundraising event that invites everybody to wear their jeans to work or school in return for a donation towards the Charity. - September 26, 2010 - FRP Advisory LLP
Noesys Data Launches a New Data Service to Identify and Classify Arrhythmias in Safety Pharmacology Studies at 10th Annual Safety Pharmacology Society Meeting
During the annual meeting of the Safety Pharmacology Society in Boston Noesys Data unveiled a service that reviews cardiac safety study data for the occurrence of arrhythmia. A panel of Board Certified veterinary cardiologists to provide expert review and customer reports. - September 24, 2010 - Noesys Data
True Health Reveals Risky Statin Drugs Can Seriously Decrease Coenzyme Q10 Levels
For those individuals taking statin drugs to help control high cholesterol such as Lipitor®, Crestor®, Pravachol® and Mevacor®, recent medical research indicates there may be an increased risk of depleting the body’s natural levels of coenzyme Q10 (CoQ10). - September 22, 2010 - True Health
Team Hope Comes to Nashville, Tennessee to Fight Huntington's Disease
South/Southwest Chapter of Huntington’s Disease Society of America Hosts Team Hope: Walk for HD to Support Local Families - September 22, 2010 - Team Hope Walk for HD
IonSense to Present Rapid Screening Solutions for Food Safety at the AOAC Annual Meeting and Exposition
DART MS Analyzes Targeted and Non-Targeted Contaminants in Seconds. - September 21, 2010 - IonSense, Inc.
Wiley-Blackwell Joins the Faculty of 1000 Affiliate Program
Serving the world's research and scholarly communities, Wiley-Blackwell is the largest publisher for professional and scholarly societies and the latest publisher to join the F1000 Affiliate Program as an affiliate publisher. - September 18, 2010 - Faculty of 1000
Proactive Medical Management Assists with Proposed OSHA Regulation Changes
JFK Medport and Insight Diagnostics, Inc. (IDI) have formed a strategic alliance that provides state of the art technology for the diagnosis and treatment of soft tissue injuries, enhancement of employee productivity and assisting employers with new Occupational Safety and Health Administration... - September 15, 2010 - Insight Diagnostics Inc
Living With Macular Degeneration
Liz Trauernicht, Director of the Macular Degeneration Foundation, and the Houston Low Vision Club will host a public discussion on the topic "Living with Macular Degeneration" at three locations in Houston during September. According to Mrs. Trauernicht, "As the leading cause of... - September 10, 2010 - Macular Degeneration Foundation
Eden Spine Receives New Patent for Its Posterior Dynamic Stabilization System, the PERFX-2
Eden Spine (www.EdenSpine.com), a Florida based Medical Devices organization focused on developing the latest generation of spinal technologies, has been granted a U.S. patent from the United States Patent and Trademark Office (USPTO) and from the European Patent Office for the PERFX-2™, a... - September 08, 2010 - Eden Spine, LLC
C.R. England and Insight Diagnostics, Inc. Announce Successful Collaboration Enhances Employee Productivity
C.R. England and Insight Diagnostics, Inc. (IDI) have formed a strategic alliance to provide state of the art technology to enhance patient care at England’s Lakeside Clinic. IDI’s FDA approved Electrodiagnostic Functional Assessment (EFA) is a Class II diagnostic device and service protocol for assessing soft tissue injuries. - August 27, 2010 - Insight Diagnostics Inc
CW Optics Announces Clinical Trial of Breakthrough Technology for Wound Imaging for Diabetics
CW Optics, Inc. announced today a clinical trial at Richmond's Chippenham and Johnston-Willis (CJW) Medical Center to investigate the safety and efficacy of WoundImager®, an advanced optical imaging device for monitoring the effectiveness of therapeutic management of chronic wounds caused by... - August 27, 2010 - CW Optics, Inc.
CW Optics Announces Clinical Trial of Breakthrough Technology for the Detection of Intravenous Infiltration
CW Optics, Inc. announced today the launch of a clinical trial at the Virginia Commonwealth University Health System to investigate the safety and efficacy of ivWatch®, a novel optical device for monitoring intravenous (IV) infusion sites for infiltration. Each year, there are approximately 150... - August 27, 2010 - CW Optics, Inc.
P.A.N.D.O.R.A. Urges Swift Action by U.S. Health Agencies to Improve Quality of Life for CFS Patients
Patients with chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME) in other countries, have endured too many years of misinformation, neglect, and mistreatment. “With a retrovirus infection now demonstrated to be present in the majority of CFS patients, now is the time... - August 25, 2010 - PANDORA Org
The Porcine microRNAome is Revealed
Results blaze a trail for advancement in pig biology as well the use of pigs as model organism for human biological and biomedical studies - August 20, 2010 - LC Sciences LLC
Commercial Insight: Multiple Sclerosis - Next Generation Therapies Signal the Start of a New Era by Datamonitor Now Available at ReportsandReports
With FDA advisory board support for Gilenia (fingolimod), Novartis will move ahead of Merck Serono's oral cladribine in the race to become the first oral multiple sclerosis therapy. - August 13, 2010 - ReportsandReports
International Specialists Gather at Taiwan's Min-Sheng General Hospital to Discuss the Use of Bariatric Surgery in the Treatment of Type II Diabetes Mellitus
Doctors from across Asia met in Taiwan to discuss the opportunities offered by gastrointestinal surgery to treat Type II Diabetes. - August 12, 2010 - Min-Sheng Hospital
Prediction of Prostate Cancer Progression Possible with Hyperspectral Imaging
A study conducted by scientists at ChemImage Corporation, in partnership with a well-known U.S. medical research and treatment center, revealed that Raman Molecular Imaging (RMI), a type of hyperspectral imaging, has potential in predicting the progression of prostate cancer. Blinded samples from... - August 11, 2010 - ChemImage Corporation
Health Market Science to Present at CBI's 4th Annual Forum on Tracking State Laws and Aggregate Spend
Presentation will address the "silver lining" in overcoming the challenge of being prepared for Aggregate Spend Regulatory Requirements. - August 11, 2010 - Health Market Science
NSF Funds Innovative Approach to Biomimetic Nanofiber Bone Regeneration
Dr. Hongjun Wang at Stevens Institute of Technology investigates a new bottom-up approach to tissue engineering. - August 06, 2010 - Stevens Institute of Technology
Novus Biologicals Releases Two New Posters to Guide Antibody Research
Novus revealed two new posters at the ISSCR 8th Annual Meeting between June 16 - 19 – a fluorescent labels poster and a stem cell signalling pathway poster. The fluorescent labels poster displays all fluorophores that Novus offers conjugated to their primary antibodies. The stem cell... - August 04, 2010 - Novus Biologicals Europe
Infonetica Has Released an Even More Interactive GCP Training
The online training solutions are the newest method giving you the opportunity of better qualification. Especially for people from clinical research field, it is very important to be up to date, but it has become even more difficult to find the convenient time between job and home... - August 04, 2010 - Infonetica Ltd
Senate Appropriations Committee Gives On-Going Support to Lupus Research Institute-Initiated National Lupus Health Education Program
Senate Recognizes Critical Need for Lupus Education, Includes $1 Million in Appropriations. - August 03, 2010 - Lupus Research Institute
Clinical Pharmacology Study Group (CPSG) Announces Open Enrollment for Psoriatic Arthritis
The Clinical Pharmacology Study Group (CPSG) is currently participating in several clinical trials for psoriatic arthritis in its Worcester, MA facility. Subjects who enroll in a clinical trial are carefully selected from a list of inclusion and exclusion criteria designed to ensure safety for the... - July 31, 2010 - Clinical Pharmacology Study Group
Medical Research: Strong Relationships with Friends/Family Decrease Risk of Death
Individuals with adequate social relationships have a 50% greater likelihood of survival compared to those with poor or insufficient social relationships. The magnitude of this effect is comparable with stopping smoking and exceeds many well known risk factors for mortality such as obesity and physical inactivity. These are the main findings of a meta-analysis of social relationships and mortality risk conducted by Julianne Holt-Lunstad (Brigham Young University, Utah, USA). - July 28, 2010 - Brigham Young University, Dr. Holt-Lunstad
Pardee Grant Will Further Pancreatic Cancer Research
Seventy-five percent of pancreatic cancer patients die within the first 12 months of their diagnosis. In a collaborative project, George Prendergast, Ph.D., Professor, President & CEO at the Lankenau Institute for Medical Research (LIMR) and Iraimoudi Ayene, Ph.D., Associate Professor at LIMR, received a one-year $125,000 grant from the Elsa U. Pardee Foundation to conduct the research project entitled Novel Immunochemotherapy for Pancreatic Cancer Treatment. - July 28, 2010 - Lankenau Institute for Medical Research
$1.85 Million Grant Explores New Treatment for Rheumatoid Arthritis
Affecting more than 1.3 million people in the United States alone, rheumatoid arthritis (RA) is a debilitating disease that causes pain, swelling, and stiffness in the joints. Dr. Laura Mandik-Nayak, Assistant Professor at the Lankenau Institute for Medical Research (LIMR), received a five-year,... - July 21, 2010 - Lankenau Institute for Medical Research
P.A.N.D.O.R.A.-Patient Alliance for Neuroendocrineimmune Disorders Organization for Research & Advocacy, Inc Wins a $20K Grant on Chase Community Giving
P.A.N.D.O.R.A., the charity organization behind the NeuroEndocrineImmune (NEI) Center™, a community patient-driven scientific research center, to be located in the state of New Jersey, wins a $20,000.00 Grant from Chase Community Giving as announced on July 13, 2010. - July 17, 2010 - PANDORA Org
ChemImage Issued Patent for Diagnosis of Kidney Cancer
ChemImage’s 106th patent acknowledges Raman Molecular Imaging (RMI) as a way to assess similar-looking tissue samples in the diagnosing of renal disease tissue. - July 15, 2010 - ChemImage Corporation
Women in Massachusetts Benefit from Health Reform, But Challenges Remain
In a new report from Brigham and Women’s Hospital, researchers examine lessons for national health reform from the Massachusetts experience. - July 14, 2010 - Brigham and Women’s Hospital
Teen-Age Boys Have Greater Risk Than Girls of High Blood Pressure as Adults
A new study found that teen boys with normal blood pressure are three to four times more likely than girls to develop high blood pressure in adulthood and at different levels of body mass, prompting researchers at Brigham and Women’s Hospital (BWH) to identify a new model to predict... - July 14, 2010 - Brigham and Women’s Hospital
Calcium/Vitamin D Supplementation Does Not Raise Coronary Artery Calcium Levels
Research from the Women's Health Initiative demonstrates that supplementation with calcium and vitamin D does not raise coronary artery calcium (CAC) levels, a strong marker for future risk of cardiovascular disease. - July 14, 2010 - Brigham and Women’s Hospital
Study of South African Population Reveals the Importance of Screening and Treating for TB in Patients with HIV
A new study reveals that the toll of TB in South Africa is higher than previously thought. - July 14, 2010 - Brigham and Women’s Hospital
Tel Aviv University Fertility Research Confirms New York Center’s DHEA Findings
Tel Aviv University's recent findings on the supplementation of DHEA to improve fertility in women with diminished ovarian reserve further confirms Center For Human Reproduction's ongoing research on this treatment. - July 13, 2010 - Center for Human Reproduction
International Stem Cell Organization Adds Notable Bioethicist to Board
The International Cellular Medicine Society (ICMS) proudly announces the addition of Glenn McGee, PhD to its Board of Directors. - July 11, 2010 - International Cellular Medicine Society
Clinical Pharmacology Study Group (CPSG) Announces Open Enrollment for Rheumatoid Arthritis Studies
The Clinical Pharmacology Study Group (CPSG) is currently participating in several clinical trials for rheumatoid arthritis in their Worcester, MA facility. Subjects who enroll in a clinical trial are carefully selected from a list of inclusion and exclusion criteria designed to ensure safety for... - June 25, 2010 - Clinical Pharmacology Study Group
Houston IVF Announces Fertility Breakthrough with First Live Births in Texas from Frozen Egg
Houston IVF recently announced the first live births of children conceived using oocyte cryopreservation, also known as egg freezing, in the state of Texas. The births pave the way to successful pregnancies for women who face cancer treatment or women who want to delay childbearing due to their career or lifestyle situations. - June 24, 2010 - Houston IVF
Lupus Research Institute Extols Power of Scientific Innovation at International Lupus Congress
Supports Bold and Pioneering Exploration in Lupus and Autoimmunity - June 23, 2010 - Lupus Research Institute
Lupus Research Institute Underscores Urgent Need for Research in Pediatric Lupus at International Lupus Congress
LRI National Coalition Backs Programming on Lupus in Children and Adolescents - June 23, 2010 - Lupus Research Institute
Simple Blood Test May Predict Who Might Develop Type 2 Diabetes Among Healthy Women - Research at Brigham and Women's Hospital
Doctors may have identified a new and simple way to predict risk for developing type 2 diabetes. - June 23, 2010 - Brigham and Women’s Hospital
Whistleblowers Report Substantial Stresses, Limited Support When Helping Expose Health Care Fraud - Research from BWH
New research evaluates the motivations and experiences of whistleblowers responsible for the recent wave of federal health care fraud cases and finds that, despite their altruistic goals, whistleblowers experience substantial hardships. - June 21, 2010 - Brigham and Women’s Hospital
Brigham Renal Division Research at the Center of an International Effort to Identify Next Generation Biomarkers to Screen Kidney Toxicity
New research has resulted in the approval of Kidney Injury Molecule-1 (Kim-1) as a highly sensitive and specific marker of drug-induced kidney injury by both the FDA and EMA. - June 21, 2010 - Brigham and Women’s Hospital
Clinical Pharmacology Study Group (CPSG) Announces Open Enrollment for Fibromyalgia Studies
The Clinical Pharmacology Study Group (CPSG) is currently participating in several clinical trials for fibromyalgia in their Worcester, MA facility. Subjects who enroll in a clinical trial are carefully selected from a list of inclusion and exclusion criteria designed to ensure safety for the... - June 18, 2010 - Clinical Pharmacology Study Group
ALPCO Diagnostics Exclusively Offers Animal NGAL Assays from BioPorto
BioPorto Diagnostics has awarded ALPCO Diagnostics exclusive distributorship for its animal NGAL ELISAs to the North American market. BioPorto’s prominence is unrivaled in immunoassays for measuring NGAL (neutrophil gelatinase associated lipocalin) – the breakthrough kidney injury... - June 17, 2010 - ALPCO
BWH Researchers Find That Using Bar-Code Technology with eMAR Drastically Reduces Medication Administration and Transcription Errors
Researchers found that using both bar-code technology and eMAR together substantially reduces transcription and medication adminstration errors. - June 13, 2010 - Brigham and Women’s Hospital
Green Light Affects Circadian Rhythms
Researchers show that green light is effective in eliciting non-visual responses to light such as resetting circadian rhythms, affecting melatonin production and alerting the brain. - June 13, 2010 - Brigham and Women’s Hospital